课题基金 / 基金详情

STAT6-dependent control of innate immunity as a target for therapeutic intervention in asthma

STAT6-dependent control of innate immunity as a target for therapeutic intervention in asthma
STAT6 依赖的先天免疫控制作为哮喘治疗干预的目标
批准号：
390066
负责人：
Fixman Elizabeth D
金额：
$64.65万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2018
资助国家：
加拿大
项目状态：
已结题
起止时间：
2018-09-01 至 2023-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=390066&lang=en
关键词：
Airway Hyperresponsiveness Asthma Innate Immunity Lung Inflammation Viral Infection

项目摘要

项目成果

Fixman Elizabeth D的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Both the incidence and severity of asthma have been increasing steadily over the last 2-3 decades. Although asthma in childhood is more prominent in boys, this sex difference changes around the time of puberty, when asthma prevalence declines in men and r
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Th17/IL-17 specific mechanisms regulating inflammation and remodeling in allergic airways disease
海外基金